Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Invested Capital: 2021-2025

Historic Invested Capital for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $1.5 billion.

  • LifeStance Health's Invested Capital rose 369.19% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 369.19%. This contributed to the annual value of $1.4 billion for FY2024, which is 63.92% up from last year.
  • Latest data reveals that LifeStance Health reported Invested Capital of $1.5 billion as of Q3 2025, which was up 369.19% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Invested Capital ranged from a high of $1.6 billion in Q4 2021 and a low of $1.4 billion during Q1 2024
  • Over the past 5 years, LifeStance Health's median Invested Capital value was $1.5 billion (recorded in 2023), while the average stood at $1.5 billion.
  • In the last 5 years, LifeStance Health's Invested Capital tumbled by 635.35% in 2023 and then skyrocketed by 369.19% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's Invested Capital stood at $1.6 billion in 2021, then fell by 1.57% to $1.5 billion in 2022, then dropped by 6.35% to $1.4 billion in 2023, then grew by 0.64% to $1.4 billion in 2024, then increased by 3.21% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.